ArticleRadiation oncology (London, England)2025
Low-dose radiotherapy for benign conditions: management of persistent inguinal lymphorrea.
Article in Radiation oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Radiotherapy for postoperative groin lymphatic fistulas: A systematic review of clinical outcomes and treatment planning.Clinical and translational radiation oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLymphorrhea is a complication that can arise after vascular, abdominal or pelvic interventions and is associated with significant morbidity. While conservative management is typically effective, some cases remain refractory.
methodsThis retrospective cross-sectional study analyzed 43 patients with persistent inguinal lymphorrhea treated at a tertiary hospital between 2008 and 2018. All patients received external beam radiotherapy (EBRT) using 3D conformal techniques with photons (6-18 MV). The delivered dose was 7.5 Gy in five 1,5 Gy/fractions.
resultsComplete closure of the lymphatic fistula was achieved in all patients. Three required reirradiation with the same schedule to reach complete resolution. No acute or late toxicity was observed in any case.
conclusionsLow-dose EBRT is a safe and effective treatment option for persistent lymphorrhea refractory to conservative measures. Its anti-inflammatory and fibrosing effects support its therapeutic use in benign lymphatic complications.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.